Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence, risk factors and treatment of central nervous system immune reconstitution inflammatory syndrome in non-HIV patients with tuberculous meningitis: a multicentre observational study.
Robert M, Mageau A, Gaudemer A, Thy M, Peiffer Smadja N, de Lastours V, De Broucker T, Papo T, Goulenok T, Sacré K. Robert M, et al. Among authors: de lastours v. Intern Med J. 2024 May;54(5):802-808. doi: 10.1111/imj.16295. Epub 2023 Dec 8. Intern Med J. 2024. PMID: 38064539
Prior participation as a standardized patient improves OSCE scores of third-year medical students: A pilot comparative study at Université Paris Cité Medical School.
Nguyen Y, Nuzzo A, Gross A, Minka O, Lilamand M, Rossi G, Sanchez M, Legué C, Pourbaix A, Tran Dinh A, Rozencwajg S, Khider L, Peiffer-Smadja N, Bouzid D, Faye A, Mirault T, de Lastours V. Nguyen Y, et al. Among authors: de lastours v. Med Teach. 2023 Oct;45(10):1177-1182. doi: 10.1080/0142159X.2023.2198665. Epub 2023 Apr 6. Med Teach. 2023. PMID: 37023786
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study.
Dinh A, Duran C, Singh S, Tesmoingt C, Bouabdallah L, Hamon A, Antignac M, Ourghanlian C, Loustalot MC, Pain JB, Wyplosz B, Junot H, Bleibtreu A, Michelon H; Temocillin Greater Paris Study Group. Dinh A, et al. JAC Antimicrob Resist. 2022 Dec 29;5(1):dlac132. doi: 10.1093/jacamr/dlac132. eCollection 2023 Feb. JAC Antimicrob Resist. 2022. PMID: 36601547 Free PMC article.
Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
Lafaurie M, Montlahuc C, Kerneis S, de Lastours V, Abgrall S, Manceron V, Couzigou C, Chabrol A, de Raigniac A, Lescure X, Longuet P, Lesprit P, Vanjak D, Lepeule R; Groupe des référents en Infectiologie d’Ile de France (GRIF). Lafaurie M, et al. Among authors: de lastours v, de raigniac a. J Antimicrob Chemother. 2023 May 3;78(5):1253-1258. doi: 10.1093/jac/dkad083. J Antimicrob Chemother. 2023. PMID: 37014800
A recurrent pleuropneumonia revealing Erdheim-Chester Disease.
Kherabi Y, Chazal T, Emile JF, Allaham W, Mallart E, de Lastours V, Haroche J, Nguyen Y. Kherabi Y, et al. Among authors: de lastours v. Respir Med Case Rep. 2023 Apr 7;43:101843. doi: 10.1016/j.rmcr.2023.101843. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37091897 Free PMC article.
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Lafaurie M, Chevret S, Fontaine JP, Mongiat-Artus P, de Lastours V, Escaut L, Jaureguiberry S, Bernard L, Bruyere F, Gatey C, Abgrall S, Ferreyra M, Aumaitre H, Aparicio C, Garrait V, Meyssonnier V, Bourgarit-Durand A, Chabrol A, Piet E, Talarmin JP, Morrier M, Canoui E, Charlier C, Etienne M, Pacanowski J, Grall N, Desseaux K, Empana-Barat F, Madeleine I, Bercot B, Molina JM, Lefort A; PROSTASHORT Study Group. Lafaurie M, et al. Among authors: de lastours v. Clin Infect Dis. 2023 Jun 16;76(12):2154-2162. doi: 10.1093/cid/ciad070. Clin Infect Dis. 2023. PMID: 36785526 Clinical Trial.
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Makhloufi S, Mellon G, de Lastours V, Bouchand F, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Perronne C, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia Short Treatment (PTC) Study Group. Dinh A, et al. Among authors: de lastours v. Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. Lancet. 2021. PMID: 33773631 Clinical Trial.
110 results